-
1
-
-
80052102622
-
Arterial thrombus formation in cardiovascular disease
-
Lippi G, Franchini M, Targher G (2011) Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 8:502-512
-
(2011)
Nat Rev Cardiol
, vol.8
, pp. 502-512
-
-
Lippi, G.1
Franchini, M.2
Targher, G.3
-
2
-
-
84555208710
-
Relationship between venous and arterial thrombosis: A review of the literature from a causal perspective
-
Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC (2011) Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost 37:885-896
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 885-896
-
-
Lijfering, W.M.1
Flinterman, L.E.2
Vandenbroucke, J.P.3
Rosendaal, F.R.4
Cannegieter, S.C.5
-
3
-
-
60549086610
-
Pathogenesis of venous thromboembolism: When the cup runneth over
-
Lippi G, Franchini M (2008) Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 34:747-761
-
(2008)
Semin Thromb Hemost
, vol.34
, pp. 747-761
-
-
Lippi, G.1
Franchini, M.2
-
4
-
-
77449121906
-
Unsuspected triggers of venous thromboembolism - Trivial or not so trivial?
-
Lippi G, Franchini M, Favaloro EJ (2009) Unsuspected triggers of venous thromboembolism - trivial or not so trivial? Semin Thromb Hemost 35:597-604
-
(2009)
Semin Thromb Hemost
, vol.35
, pp. 597-604
-
-
Lippi, G.1
Franchini, M.2
Favaloro, E.J.3
-
5
-
-
77955491421
-
The role of ethnicity, age and gender in venous thromboembolism
-
Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G (2010) The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 29:489-496
-
(2010)
J Thromb Thrombolysis
, vol.29
, pp. 489-496
-
-
Montagnana, M.1
Favaloro, E.J.2
Franchini, M.3
Guidi, G.C.4
Lippi, G.5
-
6
-
-
79953654317
-
Coagulopathies and thrombosis: Usual and unusual causes and associations, Part IV
-
Lippi G, Favaloro EJ, Franchini M (2011) Coagulopathies and thrombosis: usual and unusual causes and associations, Part IV. Semin Thromb Hemost 37:175-180
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 175-180
-
-
Lippi, G.1
Favaloro, E.J.2
Franchini, M.3
-
7
-
-
84555206142
-
Coagulopathies and thrombosis: Usual and unusual causes and associations Part v
-
Favaloro EJ, Franchini M, Lippi G (2011) Coagulopathies and thrombosis: usual and unusual causes and associations Part V. Semin Thromb Hemost 37:859-862
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 859-862
-
-
Favaloro, E.J.1
Franchini, M.2
Lippi, G.3
-
8
-
-
84870429291
-
-
The free dictionary. Definition of paradoxical. Available at: http://www.thefreedictionary.com/paradoxical
-
Definition of Paradoxical.
-
-
-
9
-
-
79251606299
-
New aspects of paradoxical embolism
-
Lehmeyer S, Lindhoff-Last E (2011) New aspects of paradoxical embolism. Vasa 40:31-40
-
(2011)
Vasa
, vol.40
, pp. 31-40
-
-
Lehmeyer, S.1
Lindhoff-Last, E.2
-
10
-
-
0036713595
-
Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease
-
Makris M, Colvin B, Gupta V, Shields ML, Smith MP (2002) Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease. Thromb Haemost 88:387-388
-
(2002)
Thromb Haemost
, vol.88
, pp. 387-388
-
-
Makris, M.1
Colvin, B.2
Gupta, V.3
Shields, M.L.4
Smith, M.P.5
-
11
-
-
12344313430
-
Thrombotic complications in patient with hereditary bleeding disorders
-
Franchini M (2004) Thrombotic complications in patient with hereditary bleeding disorders. Thromb Haemost 92:298-304
-
(2004)
Thromb Haemost
, vol.92
, pp. 298-304
-
-
Franchini, M.1
-
12
-
-
56649112761
-
Surgical prophylaxis in von Willebrand's disease: A difficult balance to manage
-
Franchini M (2008) Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage. Blood Transfus 6(Suppl. 2):S33-S38
-
(2008)
Blood Transfus
, vol.6
, Issue.SUPPL. 2
-
-
Franchini, M.1
-
13
-
-
0037079717
-
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: A prospective, multicenter study
-
Mannucci PM, Chediak J, Hanna W, Byrnes J, Marlies L, Ewenstein BM, and the Alphanate Study Group (2002) Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99:450-456
-
(2002)
Blood
, vol.99
, pp. 450-456
-
-
Mannucci, P.M.1
Chediak, J.2
Hanna, W.3
Byrnes, J.4
Marlies, L.5
Ewenstein, B.M.6
-
14
-
-
0344823956
-
Efficacy and safety of factor VIII/von Willebrand factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand's disease
-
Franchini M, Rossetti G, Tagliaferri A et al (2003) Efficacy and safety of factor VIII/von Willebrand factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand's disease. Haematologica 88:1279-1283
-
(2003)
Haematologica
, vol.88
, pp. 1279-1283
-
-
Franchini, M.1
Rossetti, G.2
Tagliaferri, A.3
-
15
-
-
77955947213
-
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors
-
Iorio A, Matino D, D'Amico R, Makris M (2010) Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors. Cochrane Database Syst Rev (8): CD004449
-
(2010)
Cochrane Database Syst Rev
, Issue.8
-
-
Iorio, A.1
Matino, D.2
D'Amico, R.3
Makris, M.4
-
16
-
-
2442529556
-
Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopedic surgery without antithrombotic prophylaxis
-
Franchini M, Tagliaferri A, Rossetti G et al (2004) Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopedic surgery without antithrombotic prophylaxis. Thromb Haemost 91:1053-1055
-
(2004)
Thromb Haemost
, vol.91
, pp. 1053-1055
-
-
Franchini, M.1
Tagliaferri, A.2
Rossetti, G.3
-
17
-
-
0022919034
-
Unstable angina associated with factor VIII concentrate therapy for hemophilia A
-
Kopitsky RG, Geltman EM (1985) Unstable angina associated with factor VIII concentrate therapy for hemophilia A. Ann Intern Med 105:215-216
-
(1985)
Ann Intern Med
, vol.105
, pp. 215-216
-
-
Kopitsky, R.G.1
Geltman, E.M.2
-
18
-
-
0026437695
-
Deep venous thrombosis in hemophilia A
-
Ritchie B, Woodman RC, Poon MC (1992) Deep venous thrombosis in hemophilia A. Am J Med 93:699-700
-
(1992)
Am J Med
, vol.93
, pp. 699-700
-
-
Ritchie, B.1
Woodman, R.C.2
Poon, M.C.3
-
19
-
-
0028784188
-
Lack of prophylactic anticoagulant therapy is not associated with clinical thrombotic complications in patients with hemophilia who undergo orthopedic surgical procedures
-
Djulbegovic B (1995) Lack of prophylactic anticoagulant therapy is not associated with clinical thrombotic complications in patients with hemophilia who undergo orthopedic surgical procedures. Am J Hematol 50:229-230
-
(1995)
Am J Hematol
, vol.50
, pp. 229-230
-
-
Djulbegovic, B.1
-
20
-
-
0035669048
-
Factor IX and thrombosis
-
Lowe GDO (2001) Factor IX and thrombosis. Br J Haematol 115:507-513
-
(2001)
Br J Haematol
, vol.115
, pp. 507-513
-
-
Lowe, G.D.O.1
-
21
-
-
0025871335
-
Thrombogenicity associated with factor IX complex concentrates
-
Lusher JM (1991) Thrombogenicity associated with factor IX complex concentrates. Semin Hematol 28:3-5
-
(1991)
Semin Hematol
, vol.28
, pp. 3-5
-
-
Lusher, J.M.1
-
22
-
-
0028361007
-
Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery
-
Santagostino E, Mannucci PM, Gringeri A et al (1994) Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Thromb Haemost 71:737-740
-
(1994)
Thromb Haemost
, vol.71
, pp. 737-740
-
-
Santagostino, E.1
Mannucci, P.M.2
Gringeri, A.3
-
23
-
-
67849110064
-
Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: When is it necessary?
-
Franchini M, Targher G, Montagnana M, Lippi G (2009) Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary? J Thromb Thrombolysis 28:215-219
-
(2009)
J Thromb Thrombolysis
, vol.28
, pp. 215-219
-
-
Franchini, M.1
Targher, G.2
Montagnana, M.3
Lippi, G.4
-
24
-
-
0028814316
-
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
-
Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152-155
-
(1995)
Lancet
, vol.345
, pp. 152-155
-
-
Koster, T.1
Blann, A.D.2
Briet, E.3
Vandenbroucke, J.P.4
Rosendaal, F.R.5
-
25
-
-
0033983988
-
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism
-
Kraaijenhagen RA, Anker PS, Koopman MMW et al (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83:5-9
-
(2000)
Thromb Haemost
, vol.83
, pp. 5-9
-
-
Kraaijenhagen, R.A.1
Anker, P.S.2
Koopman, M.M.W.3
-
26
-
-
0036712293
-
Venous thromboembolism in von Willebrand disease
-
Mannucci PM (2002) Venous thromboembolism in von Willebrand disease. Thromb Haemost 88:378-379
-
(2002)
Thromb Haemost
, vol.88
, pp. 378-379
-
-
Mannucci, P.M.1
-
27
-
-
0037079717
-
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: A prospective, multicenter study
-
Mannucci PM, Chediak J, Hanna W, Byrnes J, Marlies L, Ewenstein BM, and the Alphanate Study Group (2002) Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99:450-456
-
(2002)
Blood
, vol.99
, pp. 450-456
-
-
Mannucci, P.M.1
Chediak, J.2
Hanna, W.3
Byrnes, J.4
Marlies, L.5
Ewenstein, B.M.6
-
28
-
-
84860333511
-
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: A systematic review of prospective studies
-
2012 Feb 15. [Epub ahead of print]
-
Coppola A, Franchini M, Makris M, Santagostino E, DI Minno G, Mannucci PM (2012) Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies. Haemophilia. 2012 Feb 15. [Epub ahead of print]
-
(2012)
Haemophilia
-
-
Coppola, A.1
Franchini, M.2
Makris, M.3
Santagostino, E.4
Minno G, D.I.5
Mannucci, P.M.6
-
30
-
-
34248387034
-
Arterial and venous thrombosis in rare congenital bleeding disorders: A critical review
-
Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B (2006) Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia 12:345-351
-
(2006)
Haemophilia
, vol.12
, pp. 345-351
-
-
Girolami, A.1
Ruzzon, E.2
Tezza, F.3
Scandellari, R.4
Vettore, S.5
Girolami, B.6
-
32
-
-
76949094364
-
Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis
-
Stavrou E, Schmaier AH (2010) Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb Res 125:210-215
-
(2010)
Thromb Res
, vol.125
, pp. 210-215
-
-
Stavrou, E.1
Schmaier, A.H.2
-
33
-
-
77049208954
-
Familial hemorrhagic trait associated with deficiency of clot-promoting fraction of plasma
-
Ratnoff OD, Colopy JE (1955) Familial hemorrhagic trait associated with deficiency of clot-promoting fraction of plasma. J Clin Invest 34:602-613
-
(1955)
J Clin Invest
, vol.34
, pp. 602-613
-
-
Ratnoff, O.D.1
Colopy, J.E.2
-
34
-
-
0035071855
-
Preoperative screening: The rationale of measuring APTT in risk assessment
-
Lippi G, Franchini M, Brazzarola P, Manzato F (2001) Preoperative screening: the rationale of measuring APTT in risk assessment. Haematologica 86:328
-
(2001)
Haematologica
, vol.86
, pp. 328
-
-
Lippi, G.1
Franchini, M.2
Brazzarola, P.3
Manzato, F.4
-
35
-
-
0027351136
-
Factor XII (Hageman factor) deficiency: A risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction
-
Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M (1993) Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction. Wien Med Wochenschr 143:43-50
-
(1993)
Wien Med Wochenschr
, vol.143
, pp. 43-50
-
-
Halbmayer, W.M.1
Mannhalter, C.2
Feichtinger, C.3
Rubi, K.4
Fischer, M.5
-
36
-
-
4344609673
-
The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: A study of prevalence in 21 patients and review of the literature
-
Girolami A, Randi ML, Gavasso S, Lombardi AM, Spiezia F (2004) The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis 17:139-143
-
(2004)
J Thromb Thrombolysis
, vol.17
, pp. 139-143
-
-
Girolami, A.1
Randi, M.L.2
Gavasso, S.3
Lombardi, A.M.4
Spiezia, F.5
-
37
-
-
33845497457
-
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII
-
Doggen CJ, Rosendaal FR, Meijers JC (2006) Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood 108:4045-4051
-
(2006)
Blood
, vol.108
, pp. 4045-4051
-
-
Doggen, C.J.1
Rosendaal, F.R.2
Meijers, J.C.3
-
38
-
-
4143123359
-
Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis
-
Gallimore MJ, Harris SL, Jones DW, Winter M (2004) Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res 114:91-96
-
(2004)
Thromb Res
, vol.114
, pp. 91-96
-
-
Gallimore, M.J.1
Harris, S.L.2
Jones, D.W.3
Winter, M.4
-
39
-
-
34250191847
-
Evidence of a U-shaped association between factor XII activity and overall survival
-
Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C (2007) Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 5:1143-1148
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1143-1148
-
-
Endler, G.1
Marsik, C.2
Jilma, B.3
Schickbauer, T.4
Quehenberger, P.5
Mannhalter, C.6
-
40
-
-
78650633950
-
The factor XII-4C>T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies
-
Johnson CY, Tuite A, Morange PE, Tregouet DA, Gagnon F (2011) The factor XII-4C>T variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. Am J Epidemiol 173:136-144
-
(2011)
Am J Epidemiol
, vol.173
, pp. 136-144
-
-
Johnson, C.Y.1
Tuite, A.2
Morange, P.E.3
Tregouet, D.A.4
Gagnon, F.5
-
41
-
-
64749107219
-
Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: A risk factor for both venous and arterial thrombosis
-
Lessiani G, Falco A, Nicolucci E, Rolandi G, Davì G (2009) Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis 27:348-351
-
(2009)
J Thromb Thrombolysis
, vol.27
, pp. 348-351
-
-
Lessiani, G.1
Falco, A.2
Nicolucci, E.3
Rolandi, G.4
Davì, G.5
-
44
-
-
63349105369
-
Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia
-
Castaman G, Lunardi M, Rigo L, Mastroeni V, Bonoldi E, Rodeghiero F (2009) Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia. Haemophilia 15:533-537
-
(2009)
Haemophilia
, vol.15
, pp. 533-537
-
-
Castaman, G.1
Lunardi, M.2
Rigo, L.3
Mastroeni, V.4
Bonoldi, E.5
Rodeghiero, F.6
-
45
-
-
0343603909
-
Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia
-
Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM (1999) Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 107:204-206
-
(1999)
Br J Haematol
, vol.107
, pp. 204-206
-
-
Lak, M.1
Keihani, M.2
Elahi, F.3
Peyvandi, F.4
Mannucci, P.M.5
-
46
-
-
41849083797
-
Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes
-
Simsek I, de Mazancourt P, Horellou MH, Erdem H, Pay S, Dinc A, Samama MM (2008) Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes. Blood Coagul Fibrinolysis 19:247-253
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, pp. 247-253
-
-
Simsek, I.1
De Mazancourt, P.2
Horellou, M.H.3
Erdem, H.4
Pay, S.5
Dinc, A.6
Samama, M.M.7
-
48
-
-
0028880394
-
Severe arterial thrombosis in a congenitally factor VII deficient patient
-
Escoffre M, Zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G, Dupuy E (1995) Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 91:739-741
-
(1995)
Br J Haematol
, vol.91
, pp. 739-741
-
-
Escoffre, M.1
Zini, J.M.2
Schliamser, L.3
Mazoyer, E.4
Soria, C.5
Tobelem, G.6
Dupuy, E.7
-
49
-
-
3042822425
-
Thrombosis in inherited factor VII deficiency
-
Mariani G, Herrmann FH, Schulman S, International Factor VII Deficiency Study Group et al (2003) Thrombosis in inherited factor VII deficiency. J Thromb Haemost 1:2153-2158
-
(2003)
J Thromb Haemost
, vol.1
, pp. 2153-2158
-
-
Mariani, G.1
Herrmann, F.H.2
Schulman, S.3
-
50
-
-
43149123350
-
The paradoxical association between inherited factor VII deficiency and venous thrombosis
-
Marty S, Barro C, Chatelain B et al (2008) The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia 14:564-770
-
(2008)
Haemophilia
, vol.14
, pp. 564-770
-
-
Marty, S.1
Barro, C.2
Chatelain, B.3
-
51
-
-
84868451365
-
Congenital FVII deficiency and pulmonary embolism : A critical appraisal of all reported cases
-
2012 Feb 12. [Epub ahead of print]
-
Girolami A, Berti de Marinis G, Vettore S, Girolami B (2012) Congenital FVII deficiency and pulmonary embolism : a critical appraisal of all reported cases. Clin Appl Thromb Hemost. 2012 Feb 12. [Epub ahead of print]
-
(2012)
Clin Appl Thromb Hemost
-
-
Girolami, A.1
Berti De Marinis, G.2
Vettore, S.3
Girolami, B.4
-
52
-
-
77957936876
-
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature
-
Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B (2010) Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis 30:172-178
-
(2010)
J Thromb Thrombolysis
, vol.30
, pp. 172-178
-
-
Girolami, A.1
Tezza, F.2
Scandellari, R.3
Vettore, S.4
Girolami, B.5
-
53
-
-
33344458573
-
International concensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S, lockshin MD, Atsumi I et al (2006) International concensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, I.3
-
54
-
-
79952809635
-
The antiphospholipid syndrome: A large elephant with many parts or an elusive chameleon disguised by many colours?
-
Favaloro EJ, Wong RCW (2010) The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? Autoimmun Highlights 1:5-14
-
(2010)
Autoimmun Highlights
, vol.1
, pp. 5-14
-
-
Favaloro, E.J.1
Wong, R.C.W.2
-
55
-
-
79952797437
-
Laboratory testing for the antiphospholipid syndrome: Making sense of antiphospholipid antibody assays
-
Favaloro EJ, Wong R (2011) Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 49:447-461
-
(2011)
Clin Chem Lab Med
, vol.49
, pp. 447-461
-
-
Favaloro, E.J.1
Wong, R.2
-
57
-
-
0037370733
-
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
-
Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827-1832
-
(2003)
Blood
, vol.101
, pp. 1827-1832
-
-
Galli, M.1
Luciani, D.2
Bertolini, G.3
Barbui, T.4
-
58
-
-
84055176572
-
Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: A systematic review and metaanalysis
-
Kenet G, Aronis S, Berkun Y et al (2011) Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and metaanalysis. Semin Thromb Hemost 37:802-809
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 802-809
-
-
Kenet, G.1
Aronis, S.2
Berkun, Y.3
-
59
-
-
84861341979
-
What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
-
doi:10.1055/s-0032-1304719
-
Pengo V, Manzato A, Bison E, Bracco A, Denas G, Ruffatti A (2012) What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Semin Thromb Hemost. doi:10.1055/s-0032- 1304719
-
(2012)
Semin Thromb Hemost
-
-
Pengo, V.1
Manzato, A.2
Bison, E.3
Bracco, A.4
Denas, G.5
Ruffatti, A.6
-
60
-
-
84861343072
-
Interpretation and recommended testing for antiphospholipid antibodies
-
doi: 10.1055/s-0032-1304716
-
Galli M (2012) Interpretation and recommended testing for antiphospholipid antibodies. Semin Thromb Hemost. doi: 10.1055/s-0032-1304716
-
(2012)
Semin Thromb Hemost
-
-
Galli, M.1
-
61
-
-
84872904381
-
Acquired inhibitors of coagulation factors: Part II
-
doi: 10.1055/s-0032-1305779
-
Franchini M, Lippi G, Favaloro EJ (2012) Acquired inhibitors of coagulation factors: Part II. Semin Thromb Hemost. doi: 10.1055/s-0032-1305779
-
(2012)
Semin Thromb Hemost
-
-
Franchini, M.1
Lippi, G.2
Favaloro, E.J.3
-
62
-
-
79251520447
-
Antiphospholipid syndrome: Endocrinologic manifestations and organ involvement
-
Mehdi AA, Salti I, Uthman I (2011) Antiphospholipid syndrome: endocrinologic manifestations and organ involvement. Semin Thromb Hemost 37:49-57
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 49-57
-
-
Mehdi, A.A.1
Salti, I.2
Uthman, I.3
-
63
-
-
84861342502
-
Update on the catastrophic antiphospholipid syndrome and the "cAPS registry"
-
doi:10.1055/s-0032-1304718
-
Cervera R, Espinosa G (2012) Update on the catastrophic antiphospholipid syndrome and the "CAPS registry". Semin Thromb Hemost. doi:10.1055/s-0032-1304718
-
(2012)
Semin Thromb Hemost
-
-
Cervera, R.1
Espinosa, G.2
-
64
-
-
84861341262
-
Intensity and duration of anticoagulation therapy in the Antiphospholipid Syndrome
-
doi:10.1055/s-0032-1304720
-
Les I, Ruiz-Irastorza G, Khamashta MA (2012) Intensity and duration of anticoagulation therapy in the Antiphospholipid Syndrome. Semin Thromb Hemost. doi:10.1055/s-0032-1304720
-
(2012)
Semin Thromb Hemost
-
-
Les, I.1
Ruiz-Irastorza, G.2
Khamashta, M.A.3
|